Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae

Virology Journal

Volumn 10, Issue , 2013, Pages

  Kȩsik Szeloch, Agata ^a   Drulis Kawa, Zuzanna ^a,b   Weber Da̧browska, Beata ^b   Kassner, Jerzy ^a   Majkowska Skrobek, Grazyna ^a   Augustyniak, Daria ^a   Łusiak Szelachowska, Marzanna ^b   Zaczek, Maciej ^b   Górski, Andrzej ^b,c   Kropinski, Andrew M ^d,e  

^a UNIVERSITY OF WROC AW   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^e UNIVERSITY OF GUELPH   (Canada)

Author keywords

Bacteriophage; Klebsiella spp.; Multidrug resistance; Myoviridae; Podoviridae; Restriction endonuclease patterns; Siphoviridae

Indexed keywords

BACTERIOPHAGE DNA; CHLOROFORM; DCM METHYLTRANSFERASE; DNA ADENINE METHYLTRANSFERASE; DNA METHYLTRANSFERASE; EXTENDED SPECTRUM BETA LACTAMASE; GLUCOSYL HMC PROTEIN; HMC PROTEIN; NUCLEOTIDE; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL CELL; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA METHYLATION; ELECTRON MICROSCOPY; ENTEROBACTERIACEAE; ENZYME METABOLISM; GENE EXPRESSION; HOST PATHOGEN INTERACTION; HOST RANGE; KLEBSIELLA PNEUMONIAE; LYSIS; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PHAGE DISPLAY; PHYSICAL CHEMISTRY; PROTEIN RESTRICTION; RESPIRATORY BURST; TEMPERATURE;

ENTEROBACTERIACEAE; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; MYOVIRIDAE; PODOVIRIDAE; SIPHOVIRIDAE;

EID: 84875346054     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-100     Document Type: Article

References (48)

1. Bacteriophage ecology. Abedon ST, Population growth, evolution, and impact of bacterial viruses Cambridge, UK: Cambridge University Press, Abedon ST, 1 2008
2. Viruses: incredible nanomachines. New advances with filamentous phages. Hemminga MA, Vos WL, Nazarov PV, Koehorst RB, Wolfs CJ, Spruijt RB, Stopar D, Eur Biophys J 2010 39 541 550 10.1007/s00249-009-0523-0 19680644
3. The presence of bacteriophages in human feces and their potential importance. Łusiak-Szelachowska M, Weber-Da̧browska B, Górski A, Pol Merkur Lekarski 2006 21 381 383 17205783 (Pubitemid 44759462)
4. Phages in nature. Clokie MR, Millard AD, Letarov AV, Heaphy S, Bacteriophage 2011 1 31 45 10.4161/bact.1.1.14942 21687533
5. Phage-host interaction: an ecological perspective. Chibani-Chennoufi S, Bruttin A, Dillmann ML, Brüssow H, J Bacteriol 2004 186 3677 3686 10.1128/JB.186.12.3677-3686.2004 15175280 (Pubitemid 38746042)
6. Bacteriophage ecology in environmental biotechnology processes. Shapiro OH, Kushmaro A, Curr Opin Biotechnol 2011 22 449 455 10.1016/j.copbio.2011.01. 012 21354780
7. The role of Dam methylation in phase variation of haemophilus influenzae genes involved in defence against phage infection. Zaleski P, Wojciechowski M, Piekarowicz A, Microbiology 2005 151 3361 3369 10.1099/mic.0.28184-0 16207918 (Pubitemid 41488918)
8. Measurement of the bacteriophage inactivation kinetics with purified receptors. Kropinski AM, Methods Mol Biol 2009 501 157 160 10.1007/978-1-60327- 164-6-16 19066820
9. Bacteriophages-potential for application in wastewater treatment processes. Withey S, Cartmell E, Avery LM, Stephenson T, Sci Total Environ 2005 339 1 18 10.1016/j.scitotenv.2004.09.021 15740754 (Pubitemid 40312237)
10. Preventing biofilms of clinically relevant organisms using bacteriophage. Donlan RM, Trends Microbiol 2009 17 66 72 10.1016/j.tim.2008.11.002 19162482
11. Ecology of prokaryotic viruses. Weinbauer MG, FEMS Microbiol Rev 2004 28 127 181 10.1016/j.femsre.2003.08.001 15109783 (Pubitemid 38510500)
12. The phage-host arms race: shaping the evolution of microbes. Stern A, Sorek R, Bioessays 2011 33 43 51 10.1002/bies.201000071 20979102
13. Biology of DNA restriction. Bickle TA, Krüger DH, Microbiol Rev 1993 57 434 450 8336674 (Pubitemid 23170101)
14. Bacteriophage Resistance mechanisms. Labrie SJ, Samson JE, Moineau S, Nat Rev Microbiol 2010 8 317 327 10.1038/nrmicro2315 20348932
15. Modified bases in bacteriophage DNAs. Warren RAJ, Annu Rev Microbiol 1980 34 137 158 10.1146/annurev.mi.34.100180.001033 7002022
16. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Kutateladze M, Adamia R, Trends Biotechnol 2010 28 591 595 10.1016/j.tibtech.2010.08.001 20810181
17. European antimicrobial Resistance surveillance network http://ecdc.europa.eu/en/activities/surveillance/EARS-Net/database/Pages/ database.aspx
18. An animal farm called extended-spectrum beta-lactamase: antimicrobial resistance as a zoonosis. Pappas G, Clin Microbiol Infect 2011 17 797 798 10.1111/j.1469-0691.2011.03498.x 21463398
19. Animal reservoirs for extended spectrum beta-lactamase producers. Carattoli A, Clin Microbiol Infect 2008 14 Suppl 1 117 123 Erratum in: Clin Microbiol Infect 2008, 14 (Suppl 5):21-24 18154535 (Pubitemid 350269192)
20. Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum beta-lactamases in the UK. Warren RE, Ensor VM, O'Neill P, Butler V, Taylor J, Nye K, Harvey M, Livermore DM, Woodford N, Hawkey PM, J Antimicrob Chemother 2008 61 504 508 10.1093/jac/dkm517 18222958 (Pubitemid 351321121)
21. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van den Munckhof MP, van Essen-Zandbergen A, Platteel T, Fluit AC, van de Sande-Bruinsma N, Scharinga J, Bonten MJ, Mevius DJ, National ESBL surveillance group, Clin Microbiol Infect 2011 17 873 880 10.1111/j.1469-0691. 2011.03497.x 21463397
22. Position paper: the creation of a rational scheme for the nomenclature of viruses of bacteria and archaea. Kropinski AM, Prangishvili D, Lavigne R, Environ Microbiol 2009 11 2775 2777 10.1111/j.1462-2920.2009.01970.x 19519870
23. Classification of bacteriophages. Ackermann HW, The bacteriophages New York: Oxford University Press, Calendar R, 2 2006 8 16
24. A Dam methylation mutant of Klebsiella pneumoniae is partially attenuated. Mehling JS, Lavender H, Clegg S, FEMS Microbiol Lett 2007 268 187 193 10.1111/j.1574-6968.2006.00581.x 17328745
25. A physical genome map of pseudomonas aeruginosa PAO. Römling U, Grothues D, Bautsch W, Tümmler B, EMBO J 1989 8 4081 4089 2512121 (Pubitemid 20066850)
26. A method for generation phage cocktail with great therapeutic potential. Gu J, Liu X, Li Y, Han W, Lei L, Yang Y, Zhao H, Gao Y, Song J, Lu R, Sun C, Feng X, PLoS One 2012 7 31698 10.1371/journal.pone.0031698 22396736
27. Isolation and characterization of Klebsiella pneumoniae specific bacteriophages from sewage samples. Kumari S, Harjai K, Chhibber S, Folia Microbiol (Praha) 2010 55 221 227 10.1007/s12223-010-0032-7
28. Genome of klebsiella sp.-infecting bacteriophage vB-KleM-RaK2. Šimoliūnas E, Kaliniene L, Truncaite L, Klausa V, Zajančkauskaite A, Meškys R, J Virol 2012 86 5406 10.1128/JVI.00347-12 22492928
29. Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent. Verma V, Harjai K, Chhibber S, Curr Microbiol 2009 59 274 281 10.1007/s00284-009-9430-y 19484297
30. Characterization of extended-host-range pseudo-T-even bacteriophage Kpp95 isolated on Klebsiella pneumoniae. Wu LT, Chang SY, Yen MR, Yang TC, Tseng YH, Appl Environ Microbiol 2007 73 2532 2540 10.1128/AEM.02113-06 17337566 (Pubitemid 46668745)
31. Bacteriophage and associated polysaccharide depolymerases-novel tools for study of bacterial biofilms. Hughes KA, Sutherland IW, Clark J, Jones MV, J Appl Microbiol 1998 85 583 590 Erratum in: J Appl Microbiol 1999, 86(2):359 10.1046/j.1365-2672.1998.853541.x 9750288 (Pubitemid 28419363)
32. The enzymatic methylation of ribonucleic acid and deoxyribonucleic acid. IX. Deoxyribonucleic acid methylase in bacteriophage-infected Escherichia coli. Hausmann R, Gold M, J Biol Chem 1966 241 1985 1994 5329749
33. Evidence that Escherichia coli virus T1 induces a DNA methyltransferase. Auer B, Schweiger M, J Virol 1984 49 588 590 6319759 (Pubitemid 14175236)
34. Development of Escherichia coli virus T1: escape from host restriction. Wagner EF, Auer B, Schweiger M, J Virol 1979 29 1229 1231 376871 (Pubitemid 9124242)
35. Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice. Hung CH, Kuo CF, Wang CH, Wu CM, Tsao N, Antimicrob Agents Chemother 2011 55 1358 1365 10.1128/AAC.01123-10 21245450
36. Antibacterial efficacy of lytic bacteriophages against antibiotic-resistant Klebsiella species. Karamoddini MK, Fazli-Bazzaz BS, Emamipour F, Ghannad MS, Jahanshahi AR, Saed N, Sahebkar A, ScientificWorldJournal 2011 11 1332 1340 21789469
37. Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae. Kumari S, Harjai K, Chhibber S, J Microbiol Biotechnol 2009 19 622 628 19597322
38. Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice. Kumari S, Harjai K, Chhibber S, J Microbiol Biotechnol 2010 20 935 941 10.4014/jmb.0909.09010 20519918
39. Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055. Kumari S, Harjai K, Chhibber S, J Med Microbiol 2011 60 205 210 10.1099/jmm.0.018580-0 20965914
40. Phage choice, isolation, and preparation for phage therapy. Gill JJ, Hyman P, Curr Pharm Biotechnol 2010 11 2 14 10.2174/138920110790725311 20214604
41. The influence of external factors on bacteriophages-review. Jończyk E, Kłak M, Miȩdzybrodzki R, Górski A, Folia Microbiol (Praha) 2011 56 191 200 10.1007/s12223-011-0039-8
42. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. Ryan EM, Gorman SP, Donnelly RF, Gilmore BF, J Pharm Pharmacol 2011 63 1253 1264 10.1111/j.2042-7158.2011.01324.x 21899540
43. Bacteriophages as indicators of enteric viruses and public health risk in groundwaters. Leclerc H, Edberg S, Pierzo V, Delattre JM, J Appl Microbiol 2000 88 5 21 10735238 (Pubitemid 30140177)
44. Adams MH, Bacteriophages New York: Interscience Publishers, Inc. 1959
45. Phage typing of shigella flexneri. Ślopek S, Durlakowa I, Kucharewicz-Krukowska A, Krzywy T, Ślopek A, Weber B, Arch Immunol Ther Exp (Warsz) 1972 20 1 60
46. Phage host range and efficiency of plating. Kutter E, Bacteriophages: methods And protocols. Volume 1: isolation, characterization, and interactions New York: Humana Press, Clokie MRJ, Kropinski AM, 1 2009 141 149
47. High adsorption rate is detrimental to bacteriophage fitness in a Biofilm-like environment. Gallet R, Shao Y, Wang IN, BMC Evol Biol 2009 9 241 253 10.1186/1471-2148-9-241 19804637
48. Bacteriophage YeO3-12, specific for yersinia enterocolitica serotype O:3, is related to coliphages T3 and T7. Pajunen M, Kiljunen S, Skurnik M, J Bacteriol 2000 182 5114 5120 10.1128/JB.182.18.5114-5120.2000 10960095